CKD on Hemodialysis PatientsNCT07504302
Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital
An observational study of CKD on Hemodialysis Patients, run by Sohag University.
Trial summary
The aim of this study is to determine the prevalence of anxiety and depression among hemodialysis patients attending Sohag University Hospital and to identify the sociodemographic and clinical factors associated with these psychological disorders. Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- CKD on Hemodialysis Patients
- How many people
- 160 participants
- Where
- No sites listed yet
- Study dates
- May 2026to Sep 2026
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- Adult, Older adult
Study population: CKD on dialysis patients at Sohag University
Who may be able to join
- Patients diagnosed with end-stage renal disease (ESRD) and maintained on regular hemodialysis for at least 3 months.
- Patients aged more than 18 years old.
- Patients receiving hemodialysis three sessions per week, each lasting 3-4 hours.
- Patients who can communicate effectively and are able to complete the required questionnaires.
- Patients able to provide informed consent.
Who cannot join
- Patients suffering from major visual or hearing impairments.
- Patients with a known psychiatric disorder diagnosed prior to initiation of hemodialysis.
- Patients receiving psychiatric medications or active psychotherapy.
- Patients with severe cerebrovascular diseases.
- Patients with chronic liver diseases, lung diseases or malignancies that can add additional psychological burden.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
The aim of this study is to determine the prevalence of anxiety and depression among hemodialysis patients attending Sohag University Hospital and to identify the sociodemographic and clinical factors associated with these psychological disorders.
The study is a descriptive cross-sectional study conducted on patients undergoing maintenance hemodialysis at the Hemodialysis Unit, Sohag University Hospital.
- Conditions
- CKD on Hemodialysis Patients
- Being tested
- No Interventions
- Keywords
- Anxiety, Depression, hemodialysis patients
- Medical subject headings
- Anxiety Disorders, Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No InterventionsOther
No interventions
| Study group | Role | What they receive |
|---|---|---|
| CKD on dialysis patients | Not described Receives: Other: No Interventions |
What is being measured
The primary outcome is the main question the study is designed to answer.
Questionnaire for the Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital
Measured: From enrollment to the end of treatment at 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Mar 2026
- Study startMay 2026 (estimated)
- Primary completionSep 2026 (estimated)
- Study completionSep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CKD on Hemodialysis PatientsStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 160 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Norhan Hussien, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07504302
- Sponsor's protocol ID
- Soh-Med-26-2-7MS
- Status last verified
- Feb 2026
- First submitted
- 28 Feb 2026
- Last updated
- 31 Mar 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 31 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital
- ClinicalTrials.gov ID
- NCT07504302
- Acronym / sponsor ID
- Soh-Med-26-2-7MS
- Conditions
- CKD on Hemodialysis Patients
- Keywords
- Anxiety, Depression, hemodialysis patients
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 160 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- May 2026 (estimated)
- Primary completion
- Sep 2026 (estimated)
- Study completion
- Sep 2026 (estimated)
- First posted
- 31 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to determine the prevalence of anxiety and depression among hemodialysis patients attending Sohag University Hospital and to identify the sociodemographic and clinical factors associated with these psychological disorders.
The study is a descriptive cross-sectional study conducted on patients undergoing maintenance hemodialysis at the Hemodialysis Unit, Sohag University Hospital.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| CKD on dialysis patients | – | Other: No Interventions |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- CKD on dialysis patients at Sohag University
Key inclusion criteria (5 listed)
- Patients diagnosed with end-stage renal disease (ESRD) and maintained on regular hemodialysis for at least 3 months.
- Patients aged more than 18 years old.
- Patients receiving hemodialysis three sessions per week, each lasting 3-4 hours.
- Patients who can communicate effectively and are able to complete the required questionnaires.
- Patients able to provide informed consent.
Key exclusion criteria (5 listed)
- Patients suffering from major visual or hearing impairments.
- Patients with a known psychiatric disorder diagnosed prior to initiation of hemodialysis.
- Patients receiving psychiatric medications or active psychotherapy.
- Patients with severe cerebrovascular diseases.
- Patients with chronic liver diseases, lung diseases or malignancies that can add additional psychological burden.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No InterventionsNo interventions | Other | CKD on dialysis patients |
Primary outcome
Questionnaire for the Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital
Time frame: From enrollment to the end of treatment at 8 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Mar 2026.
- Individual participant dataSharing planned: Undecided
Related trials for CKD on Hemodialysis Patients
Not yet recruiting
Manual Acupuncture for Intradialytic Nausea and Vomiting in Patients Undergoing Hemodialysis
Intradialytic Nausea and Vomiting, Chronic Kidney Disease
Not yet recruiting
Evaluation of the Effect of Light Therapy on the Evolution of Self-reported Depressive Disorders in Chronic Hemodialysis Patients
End-stage Chronic Kidney Disease Treated With Hemodialysis, Depressive Disorders
RecruitingObservational study
Nutritional Status in Patients With Chronic Kidney Disease Receiving 7.2% Amino Acids During Hemodialysis
Malnutitrion, Chronic Kidney Disease on Hemodialysis
Active, not recruiting
Egg Albumin and Agave Fructans With Exercise in Hemodialysis
Sarcopenia, Chronic Kidney Disease
RecruitingObservational study
Bicarbonate HD Study
Metabolic Acidosis, CKD on Hemodialysis Patients
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of CKD on Hemodialysis Patients, run by Sohag University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 31 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Norhan Hussien Abd El-Rheem (+201147088030, norhanhussein97@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Questionnaire for the Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital (time frame: From enrollment to the end of treatment at 8 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2026.